BMA accuses campaign of glamorising smoking " /> BMA accuses campaign of glamorising smoking " />

Please login to the form below

Not currently logged in
Email:
Password:

UK e-cigarette advert comes under fire

BMA accuses campaign of glamorising smoking



The first televised advertisements for electronic cigarettes in the UK have prompted numerous complaints to regulatory body the Advertising Standards Authority, accusing the makers of glamorising smoking and targeting children.

The British Medical Association (BMA) wrote to the ASA, claiming the campaign for VIP e-cigarettes sexualises and glamorises e-cigarettes.

“[The advertisement] directly contravenes regulations stating that marketing for e-cigarettes must be socially responsible and must not appeal to non-smokers,” said the BMA's letter.

Dr Mark Porter, chair of the BMA council, said: “We have repeatedly highlighted our concerns that the promotion of e-cigarettes may have an adverse impact of re-normalising smoking and indirectly promoting tobacco smoking, and that advertising rules should ensure the marketing of e-cigarettes does not appeal to children.

“It is deeply concerning that these rules are being completely ignored so soon after coming into force. This advert makes no reference to the fact that the product is intended as a replacement for tobacco.”

Article by
Kirstie Pickering

25th November 2014

From: Marketing, Healthcare

Share

Tags

BMA accuses campaign of glamorising smoking] \[` public health` `smoking` `e-cigarettes `\] \[` advertisingbranding `\] [] -->

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics